Oxford BioDynamics Plc (LON:OBD – Get Free Report)’s stock price traded up 5.3% during mid-day trading on Monday . The stock traded as high as GBX 0.18 and last traded at GBX 0.18. 3,021,327 shares traded hands during trading, a decline of 78% from the average daily volume of 14,009,450 shares. The stock had previously closed at GBX 0.17.
Oxford BioDynamics Price Performance
The company has a quick ratio of 2.80, a current ratio of 0.88 and a debt-to-equity ratio of 457.97. The stock’s 50-day moving average price is GBX 0.19 and its 200 day moving average price is GBX 0.23. The firm has a market cap of £7.72 million, a price-to-earnings ratio of -0.22 and a beta of 0.42.
Oxford BioDynamics Company Profile
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Featured Stories
- Five stocks we like better than Oxford BioDynamics
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
